Pharmacologic Management of Pain in Adults
First-Line Therapy for Mild to Moderate Nociceptive Pain
Acetaminophen 1000 mg every 4-6 hours (maximum 4 g/24 hours) is the recommended first-line agent for mild to moderate nociceptive pain due to its superior safety profile compared to NSAIDs. 1, 2
- Acetaminophen is as effective as NSAIDs for osteoarthritis and low back pain but avoids gastrointestinal bleeding, renal toxicity, and cardiovascular complications. 1, 3
- The maximum safe dose is 4 g/24 hours from all sources combined; educate patients to check for acetaminophen in combination products. 1
- In patients with decompensated cirrhosis or severe alcohol use disorder, reduce the total daily dose to 2-3 g/day and individualize dosing in consultation with their physician. 3
- No routine dose reduction is required for elderly patients or those with stable chronic liver disease, mild-to-moderate renal impairment, cardiovascular disease, or asthma. 3
When to Add or Switch to NSAIDs
- NSAIDs are preferred over acetaminophen for inflammatory pain, particularly bone pain. 1
- Topical NSAIDs are first-line for non-low back musculoskeletal injuries to minimize systemic adverse effects. 2
- Nonselective NSAIDs (ibuprofen, naproxen) are effective but contraindicated in patients with:
- COX-2 selective inhibitors (celecoxib) reduce GI bleeding risk but carry equal or greater cardiovascular risk and are more expensive; reserve for patients with high GI bleeding risk and low cardiovascular risk. 5, 4
- Never combine NSAIDs with methotrexate due to severe toxicity risk. 1
Escalation for Severe or Refractory Nociceptive Pain
If acetaminophen or NSAIDs fail, add tramadol 50 mg every 6 hours (titrate to 200-400 mg/day) or use acetaminophen/opioid combinations for severe acute pain. 2, 6
- Tramadol is effective for patients who cannot tolerate NSAIDs and provides analgesia through dual opioid and monoamine reuptake mechanisms. 2, 6
- For severe acute pain requiring opioids, prescribe the shortest duration possible (typically 3-7 days) and counsel on proper disposal of unused medication. 5, 2
- Opioids carry risks of respiratory depression, cognitive impairment, and addiction; use only when non-opioid options are inadequate. 4
First-Line Therapy for Neuropathic Pain
Gabapentin is first-line for neuropathic pain; start at 300 mg once daily and titrate to 1800-3600 mg/day in three divided doses over 3-8 weeks. 7, 8
Gabapentin Titration Protocol
- Day 1: 300 mg at bedtime.
- Day 2: 300 mg twice daily (600 mg/day).
- Day 3: 300 mg three times daily (900 mg/day).
- Thereafter: Increase by 300 mg every 3-7 days until reaching 1800 mg/day (600 mg three times daily), which is the minimum effective dose. 7
- Maximum dose: 3600 mg/day (1200 mg three times daily) if pain persists. 7, 8
- Three-times-daily dosing is mandatory due to saturable, nonlinear absorption; once- or twice-daily regimens lead to treatment failure. 7, 8
Special Populations
- Elderly patients: Start at 100-200 mg/day and titrate more slowly (every 3-7 days or longer) to reduce fall risk from dizziness (19% incidence) and somnolence (14% incidence). 7
- Renal impairment: Mandatory dose reduction based on creatinine clearance (calculate using Cockcroft-Gault): 7, 8
| CrCl (mL/min) | Total Daily Dose | Frequency |
|---|---|---|
| ≥60 | 900-3600 mg | Three times daily |
| 30-59 | 400-1400 mg | Twice daily |
| 15-29 | 200-700 mg | Once daily |
| <15 | 100-300 mg | Once daily |
Expected Outcomes and Trial Duration
- 32-38% of patients achieve ≥50% pain reduction with gabapentin 1800-3600 mg/day versus 17-21% with placebo. 7, 8
- Allow 3-8 weeks for titration plus 2 weeks at maximum tolerated dose (total ~2 months) before declaring treatment failure, as efficacy develops gradually. 7, 8
Critical Pitfalls
- Do not use gabapentin for chemotherapy-induced peripheral neuropathy (CIPN)—it lacks efficacy in this setting despite common insurance requirements. 8
- Do not rush titration in elderly patients; slower increments reduce dizziness-related falls. 7
- Do not discontinue abruptly; taper over ≥1 week to avoid withdrawal symptoms. 7
Alternative and Combination Therapy for Neuropathic Pain
If Gabapentin Fails or Is Not Tolerated
Switch to pregabalin 75 mg twice daily (150 mg/day), increase to 300 mg/day within 1 week, and titrate to 600 mg/day in divided doses if needed. 7, 9
- Pregabalin has linear pharmacokinetics (more predictable dosing than gabapentin) and can be dosed twice daily. 7
- Titrate by 150 mg every 3-7 days to minimize dizziness and somnolence; allow 2-4 weeks at 600 mg/day before declaring failure. 9
- Renal dose adjustment is also mandatory for pregabalin. 9
Combination Therapy for Refractory Neuropathic Pain
Add nortriptyline 10-25 mg nightly and titrate every 3-5 days to 50-150 mg nightly if gabapentin or pregabalin monotherapy fails. 8, 9
- Nortriptyline (or desipramine) provides synergistic analgesia when combined with gabapentin or pregabalin and is better tolerated than tertiary-amine TCAs (amitriptyline, imipramine). 8
- Analgesic benefit appears within days at lower doses (50-150 mg) compared to weeks required for antidepressant effects. 8
- Obtain baseline ECG if patient is >40 years old before starting; limit dose to <100 mg/day in patients with cardiac disease. 9
- Reserve amitriptyline or imipramine for patients who fail secondary-amine TCAs, as they cause more anticholinergic side effects (sedation, dry mouth, urinary retention, confusion). 1, 8
Adjunctive Topical Therapy
Apply lidocaine 5% patches to localized painful areas once daily; they can be safely combined with systemic agents. 8, 9
- Topical agents provide localized analgesia without systemic drug interactions or absorption. 8
- Capsaicin 8% patch (single 30-minute application) provides pain relief lasting ≥12 weeks for postherpetic neuralgia. 7
HIV-Associated Neuropathic Pain
For chronic HIV-associated neuropathic pain, titrate gabapentin to 2400 mg/day over 4 weeks in divided doses. 7
- Gabapentin improves pain intensity scores and sleep quality in HIV neuropathy. 7
- Somnolence occurs in ~80% of patients at 2400 mg/day; counsel patients accordingly. 7
Muscle Relaxants for Acute Low Back Pain
Baclofen 5 mg up to three times daily (maximum 30-40 mg/day in older adults) or tizanidine 2 mg up to three times daily may be added for acute low back pain with muscle spasm. 1
- Monitor for muscle weakness, urinary dysfunction, cognitive effects, sedation, and orthostasis. 1
- Avoid abrupt discontinuation of baclofen due to CNS irritability and withdrawal risk. 1
- Older adults rarely tolerate baclofen doses >30-40 mg/day. 1
Key Contraindications and Precautions
Acetaminophen
- Hepatotoxicity risk: Reduce dose to 2-3 g/day in decompensated cirrhosis, severe alcohol use disorder, or malnutrition. 1, 3
- Safe in stable chronic liver disease, renal impairment, cardiovascular disease, and elderly patients at standard doses. 3
NSAIDs
- Contraindicated in: Active GI bleeding, severe renal impairment (CrCl <30 mL/min), heart failure, recent MI or stroke. 2, 4
- Avoid with: Anticoagulation (increased bleeding risk), methotrexate (severe toxicity), nephrotoxic chemotherapy (cisplatin). 1
Opioids
- Avoid in obstructive sleep apnea due to respiratory depression risk. 2
- Use extreme caution in substance use disorder; consider buprenorphine/naloxone for patients on medication-assisted therapy. 2
- Elderly patients are at higher risk for cognitive impairment, falls, and constipation. 1, 4
Gabapentin/Pregabalin
- Mandatory renal dose adjustment; failure to reduce dose in renal impairment causes excessive sedation and fall risk. 7, 8
- Elderly patients require slower titration and lower effective doses. 7
Tricyclic Antidepressants
- Contraindicated in: Recent MI, uncontrolled arrhythmias, narrow-angle glaucoma, urinary retention. 1
- Anticholinergic side effects (confusion, constipation, urinary retention) are enhanced by neurological disease and aging. 1
Referral to Pain Specialist
Refer to a pain specialist if trials of optimized first-line medications in combination fail, or if complex comorbidities, substance use concerns, or severe functional impairment are present. 9